181 related articles for article (PubMed ID: 28189179)
1. Unusual Anemias.
Daughety MM; DeLoughery TG
Med Clin North Am; 2017 Mar; 101(2):417-429. PubMed ID: 28189179
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
3. Successful cholecystectomy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria during eculizumab treatment.
Ando K; Gotoh A; Yoshizawa S; Gotoh M; Iwabuchi T; Ito Y; Ohyashiki K
Ann Hematol; 2012 Dec; 91(12):1987-8. PubMed ID: 22739575
[No Abstract] [Full Text] [Related]
4. Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis.
Pagliuca S; Risitano AM; De Fontbrune FS; Robin M; Iori AP; Marotta S; Michonneau D; Villate A; Desmier D; Socié G; De Latour RP
Bone Marrow Transplant; 2018 Jan; 53(1):105-107. PubMed ID: 29131151
[No Abstract] [Full Text] [Related]
5. Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Selleri C; Serio B; Risitano AM
Mini Rev Med Chem; 2011 Jun; 11(6):536-43. PubMed ID: 21561402
[TBL] [Abstract][Full Text] [Related]
6. Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
Asano J; Ueda R; Tanaka Y; Shinzato I; Takafuta T
Intern Med; 2014; 53(2):125-8. PubMed ID: 24429452
[TBL] [Abstract][Full Text] [Related]
7. Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.
Bauters T; Bordon V; Robays H; Benoit Y; Dhooge C
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e346-8. PubMed ID: 22767128
[TBL] [Abstract][Full Text] [Related]
8. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
10. Hyporegenerative processes in hemolytic anemia.
Bauman AW; Swisher SN
Semin Hematol; 1967 Jul; 4(3):265-72. PubMed ID: 4864464
[No Abstract] [Full Text] [Related]
11. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Invited Lecture; 3. Pathophysiology and treatment of bone marrow failure syndromes].
Ozawa K
Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2062-73. PubMed ID: 27522754
[No Abstract] [Full Text] [Related]
12. Erythroid marrow function in anemic patients.
Cazzola M; Pootrakul P; Huebers HA; Eng M; Eschbach J; Finch CA
Blood; 1987 Jan; 69(1):296-301. PubMed ID: 3098323
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 4. Paroxysmal nocturnal hemoglobinuria].
Nishimura J; Kanakura Y
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1953-9. PubMed ID: 22896999
[No Abstract] [Full Text] [Related]
14. Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience.
Griffin M; Kulasekararaj A; Gandhi S; Munir T; Richards S; Arnold L; Benson-Quarm N; Copeland N; Duggins I; Riley K; Hillmen P; Marsh J; Hill A
Haematologica; 2018 Aug; 103(8):e345-e347. PubMed ID: 29545341
[No Abstract] [Full Text] [Related]
15. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
16. Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia.
Brodsky RA
Ann Intern Med; 2008 Apr; 148(8):587-95. PubMed ID: 18413620
[No Abstract] [Full Text] [Related]
17. [Discussion meeting on the treatment of intractable anemia (bone marrow failure syndromes)].
Ozawa K; Hangaishi A; Yamazaki H; Okutomi K; Sugimoto M
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):2016-33. PubMed ID: 22897007
[No Abstract] [Full Text] [Related]
18. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 2. Paroxysmal nocturnal hemoglobinuria].
Kawaguchi T
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1891-7. PubMed ID: 22896991
[No Abstract] [Full Text] [Related]
19. [PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. REPORT OF 8 CASES WITH SPECIAL REGARD TO PANTOCYTOPENIA AND BONE MARROW APLASIA].
CHROBAK L; BRABEE V; WIEDERMANN B; DONNER L; FRIEDMANN B; PUDLAK P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1964; 82():256-93. PubMed ID: 14342555
[No Abstract] [Full Text] [Related]
20. Erythropoiesis in paroxysmal nocturnal hemoglobinuria.
Ruvidić R; Biljanović-Paunović L; Pendić S; Mijović A; Bosković D; Pavlović-Kentera V
Acta Med Iugosl; 1990; 44(5):447-56. PubMed ID: 2077818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
